Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells

Endocrinology

Volumn 150, Issue 4, 2009, Pages 1597-1606

  Fang, Feng ^a   Rycyzyn, Michael A ^b   Clevenger, Charles V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; SMALL INTERFERING RNA; STAT5 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; PROLACTIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 63849258679     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1079     Document Type: Article

References (72)

1. Clevenger CV, Plank TL 1997 Prolactin as an autocrine/paracrine factor in breast tissue. J Mammary Gland Biol Neoplasia 2:59-68
2. Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE, Holly JM 2004 Prolactin acts as a potent survival factor for human breast cancer cell lines. Br J Cancer 91:305-311
3. Maus MV, Reilly SC, Clevenger CV 1999 Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 140:5447-5450
4. Horseman ND1999 Prolactin and mammary gland development. J Mammary Gland Biol Neoplasia 4:79 -88
5. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C 1994 Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci USA 91:5232-5236
6. Rui H, Lebrun JJ, Kirken RA, Kelly PA, Farrar WL 1994 JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135:1299 -1306
7. Gadd SL, Clevenger CV 2006 Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol 20:2734 -2746
8. Beck MT, Peirce SK, Chen WY 2002 Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R. Oncogene 21:5047-5055
9. Brockman JL, Schroeder MD, Schuler LA 2002 PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16:774 -784
10. Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Gonzalez L, Porque PG, Leon J, Martin-Perez J 2004 Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Oncogene 23:7378 -7390
11. Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H 2000 Prolactin enhances CCAAT enhancer-binding protein-β (C/EBPβ) and peroxisome prolif- erator-activated receptor γ (PPARγ) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 14:307-316
12. Clevenger CV, Zheng J, Jablonski EM, Galbaugh TL, Fang F 2008 From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics. J Mammary Gland Biol Neoplasia 13:147-156
13. Darnell Jr JE, Kerr IM, Stark GR1994 Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
14. Wagner KU, Rui H 2008 Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mammary Gland Biol Neoplasia 13:93-103
15. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746 -760
16. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN 1998 Jak2 is essential for signaling through a varietyofcytokine receptors. Cell 93:385-395
17. Darnell Jr JE 1996 Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc Natl Acad Sci USA 93:6221-6224
18. Clevenger CV 2004 Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 165:1449 -1460
19. Wyszomierski SL, Rosen JM 2001 Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPβ (CCAAT/enhancer-bind- ing protein-β)on β-casein gene transcription are mediated by the glucocorti- coid receptor. Mol Endocrinol 15:228 -240
20. Zhu M, John S, Berg M, Leonard WJ 1999 Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling. Cell 96:121-130
21. Xu BC, Wang X, Darus CJ, Kopchick JJ 1996 Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem 271:19768 -19773
22. Cella N, Groner B, Hynes NE 1998 Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Mol Cell Biol 18:1783-1792
23. Hilton DJ 1999 Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55:1568 -1577
24. Starr R, Hilton DJ 1998 SOCS: suppressors of cytokine signalling. Int J Bio-chem Cell Biol 30:1081-1085
25. Shuai K 2000 Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19:2638 -2644
26. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K 1998 Inhibition ofStat1-mediated gene activation byPIAS1. Proc Natl Acad Sci USA 95:10626 -10631
27. Rycyzyn MA, Clevenger CV 2002 The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 99:6790 -6795
28. Weston K 1999 Reassessing the role of C-MYB in tumorigenesis. Oncogene 18:3034 -3038
29. Ness SA1999 Myb binding proteins: regulators and cohorts in transformation. Oncogene 18:3039 -3046
30. O'Rourke JP, Ness SA 2008 Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities. Mol Cell Biol 28:2091-2101
31. Lei W, Liu F, Ness SA 2005 Positive and negative regulation of c-Myb bycyclin D1, cyclin-dependent kinases, and p27 Kip1. Blood 105:3855-3861
32. Tahirov TH, Sato K, Ichikawa-Iwata E, Sasaki M, Inoue-Bungo T, Shiina M, Kimura K, Takata S, Fujikawa A, Morii H, Kumasaka T, Yamamoto M, Ishii S, Ogata K 2002 Mechanism of c-Myb-C/EBPβ cooperation from separated sites on a promoter. Cell 108:57-70
33. Andersson KB, Kowenz-Leutz E, Brendeford EM, Tygsett AH, Leutz A, Gabrielsen OS 2003 Phosphorylation-dependent down-regulation of c-Myb DNA binding is abrogated by a point mutation in the v-myb oncogene. J Biol Chem 278:3816 -3824
34. Goupille O, Barnier JV, Guibert B, Paly J, Djiane J 2000 Effect of PRL on MAPK activation: negative regulatory role of the C-terminal part of the PRL receptor. Mol Cell Endocrinol 159:133-146
35. Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS 1995 Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lym- phoma cells. Endocrinology 136:5252-5259
36. Leverson JD, Ness SA 1998 Point mutations in v-Myb disrupt a cyclophilin- catalyzed negative regulatory mechanism. Mol Cell 1:203-211
37. Ren S, Cai HR, Li M, Furth PA 2002 Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21:4335-4339
38. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22:2053-2060
39. Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth PA 2004 Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 108:665-671
40. Lutwyche JK, Keough RA, Hunter J, Coles LS, Gonda TJ 2006 DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein. Biochem Biophys Res Commun 344:1300 -1307
41. Pfitzner E, Jahne R, Wissler M, Stoecklin E, Groner B 1998 p300/CREB- binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol 12:1582-1593
42. Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J, Borg A 2000 MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 60:5323-5328
43. Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, Wu Y, Allred DC 2007 Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol 171:252-262
44. McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV 2008 Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 21:565-571
45. Guerin M, Sheng ZM, Andrieu N, Riou G 1990 Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene 5:131-135
46. Gudas JM, Klein RC, Oka M, Cowan KH 1995 Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Clin Cancer Res 1:235-243
47. Drabsch Y, Hugo H, Zhang R, Dowhan DH, Miao YR, Gewirtz AM, Barry SC, Ramsay RG, Gonda TJ2007 Mechanism of and requirement for estrogen- regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci USA 104:13762-13767
48. Fang F, Antico G, Zheng J, Clevenger CV 2008 Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol 8:11
49. Sotiropoulos A, Moutoussamy S, Renaudie F, Clauss M, Kayser C, Gouilleux F, Kelly PA, Finidori J 1996 Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol Endocrinol 10:998 -1009
50. Gouilleux F, Wakao H, Mundt M, Groner B 1994 Prolactin induces phos- phorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 13:4361-4369
51. Bies J, Nazarov V, Wolff L 1999 Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias. J Virol 73:2038 -2044
52. Schurmann A, Sokolowski R, Haas M, Wolfes H 2001 Characterization of direct readout contacts of the Myb DNA-binding domain. Blood Cells Mol Dis 27:464-469
53. Miller SL, DeMaria JE, Freier DO, Riegel AM, Clevenger CV 2005 Novel association of Vav2 and Nek3 modulates signaling through the human pro- lactin receptor. Mol Endocrinol 19:939 -949
54. Berge T, Matre V, Brendeford EM, Saether T, Luscher B, Gabrielsen OS 2007 Revisiting a selection oftarget genes for the hematopoietic transcription factor c-Myb using chromatin immunoprecipitation and c-Myb knockdown. Blood Cells Mol Dis 39:278 -286
55. Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F, Mentens N, Beverloo HB, Pieters R, Speleman F, Odero MD, Bauters M, FroyenG, MarynenP, Vandenberghe P, WlodarskaI, MeijerinkJP, Cools J 2007 Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 39:593-595
56. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, Yu AL 2008 MiR-150 negativelyregulatesc-Mybexpression, which is evolutionarily conserved and plays an important role in developmental process. Mol Biol Evol 25:2189 -2198
57. Shiu RP, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B 1987 Biological actions of prolactin in human breast cancer. Recent Prog Horm Res 43:277-303
58. + T-cells. Leuk Res 28:71-82
59. Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, Garcia-Caballero T, Li H, Brown RJ, McGuckin MA, Morel G, Waters MJ 2003 Suppressor of cy- tokine signalling gene expression is elevated in breast carcinoma. Br J Cancer 89:524 -532
60. Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H 2006 Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. J Endocrinol 188:589 -601
61. Pezet A, Favre H, Kelly PA, Edery M 1999 Inhibition and restoration of pro- lactin signal transduction by suppressors of cytokine signaling. J Biol Chem 274:24497-24502
62. Borges S, Moudilou E, Vouyovitch C, Chiesa J, Lobie P, Mertani H, Raccurt M 2008 Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer. Adv Exp Med Biol 617:321-329
63. Salomoni P, Perrotti D, Martinez R, Franceschi C, Calabretta B 1997 Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci USA 94:3296 -3301
64. Liu F, Lei W, O'Rourke JP, Ness SA 2006 Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb. Oncogene 25:795-805
65. Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G, Ishii S 1992 Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7:1233-1240
66. Mink S, Kerber U, Klempnauer KH 1996 Interaction of C/EBPβ and v-Myb is required for synergistic activation of the mim-1 gene. Mol Cell Biol 16:1316 -1325
67. Yu-Lee LY, Luo G, Book ML, Morris SM 1998 Lactogenic hormone signal transduction. Biol Reprod 58:295-301
68. Vidarsson H, Mikaelsdottir EK, Rafnar T, Bertwistle D, Ashworth A, Eyfjord JE, Valgeirsdottir S 2002 BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity. FEBS Lett 532:247-252
69. Pircher TJ, Petersen H, Gustafsson JA, Haldosen LA 1999 Extracellular signal- regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol Endocrinol 13:555-565
70. Yang J, Stark GR 2008 Roles of unphosphorylated STATs in signaling. Cell Res 18:443-451
71. Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, Bhardwaj B, Fujimoto N 1995 Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol 53:387-393
72. Wang X, Seed B 2003 A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31:e154